glp-1 receptor agonists effects on cardiovascular risk reduction and outcome trials: An update Mechanisms of action and effects
Description
doi: 10.1038/304368a0 [DOI] [PubMed] [Google Scholar] 21
Chirico M, Cherian S, Anderson S, et al
Long term use of beinaglutide, a recombinant human GLP-1(7-36) acid, was demonstrated to reduce the body weight and improve steatosis (194)
The actual systemic exposure to the infant approaches zero through two independent mechanisms
[PMCID:PMC11043712]
doi: 10.1530/EJE-21-0972, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 146
